Human Molecular Genetics Advance Access published online on July 14, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh206
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 INSERM U613, 29200 Brest, France; Etablissement Français du Sang, 29200 Brest, France
* To whom correspondence should be addressed. E-mail: claude.ferec{at}univ-brest.fr.
The most common form of hereditary haemochromatosis is an adult-onset condition usually associated with the HFE C282Y/C282Y genotype. The phenotypic expression of this genotype is heterogeneous and depends on a complex interplay of genetic and non-genetic factors. The aim of the present study was to determine if mutations in the recently identified HJV gene were associated with more severe iron overload phenotypes in C282Y homozygous patients. From a cohort of 310 C282Y homozygous patients, we found nine (six males and three females) with an additional HJV missense mutation in the heterozygous state (S105L, E302K, N372D, R335Q or the previously described L101P and G320V). The iron indices of 8 patients appeared to be more severe than those observed in C282Y homozygous patients of identical sex and similar age ranges. The mean serum ferritin concentration of the 6 males with an HJV mutation was significantly higher than that of C282Y homozygous males without an additional mutation (2350.3 [
Article
The recently identified type 2A juvenile haemochromatosis gene (HJV), a second canditate modifier of the C282Y homozygous phenotype
2 INSERM U613, 29200 Brest, France
3 INSERM U613, 29200 Brest, France; Université de Bretagne Occidentale, 29200 Brest, France
4 Etablissement Français du Sang, 29200 Brest, France
5 INSERM U613, 46, rue Felix Le Dantec, 29275 Brest, France; Etablissement Français du Sang, 29200 Brest, France; Université de Bretagne Occidentale, 29200 Brest, France
Abstract 
= 1429.9] vs 1227.2 [ = 1130.1] µg/L; p = 0.0233, Student t test). We have recently reported that mutations in the gene that encodes hepcidin (HAMP) could explain one part of the C282Y/C282Y-related phenotypic heterogeneity by accentuating the iron burden. Our new data reveals that mutations in the HJV gene could be associated with a similar effect. Taken together, these results emphasize that a search for modifier genes could enable us to more precisely distinguish those C282Y homozygous patients with a higher risk to develop a severe iron overload and, consequently, clinical complications.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.-L. Island, A.-M. Jouanolle, A. Mosser, Y. Deugnier, V. David, P. Brissot, and O. Loreal A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis Haematologica, May 1, 2009; 94(5): 720 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Ajioka, J. D. Phillips, R. B. Weiss, D. M. Dunn, M. W. Smit, S. C. Proll, M. G. Katze, and J. P. Kushner Down-regulation of hepcidin in porphyria cutanea tarda Blood, December 1, 2008; 112(12): 4723 - 4728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Andrews Forging a field: the golden age of iron biology Blood, July 15, 2008; 112(2): 219 - 230. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Wood, L. W. Powell, and G. A. Ramm Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis Blood, May 1, 2008; 111(9): 4456 - 4462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Silvestri, A. Pagani, and C. Camaschella Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis Blood, January 15, 2008; 111(2): 924 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cunat, M. Giansily-Blaizot, M. Bismuth, F. Blanc, O. Dereure, D. Larrey, A. L. Quellec, P. Pouderoux, C. Rose, I. Raingeard, et al. Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders Clin. Chem., December 1, 2007; 53(12): 2060 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. C. van Dijk, E. H. J. M. Kemna, H. Tjalsma, S. M. Klaver, E. T. G. Wiegerinck, J.-P. Goossens, P. H. Th. J. Slee, M. H. Breuning, and D. W. Swinkels Effect of the new HJV-L165X mutation on penetrance of HFE Blood, June 15, 2007; 109(12): 5525 - 5526. [Full Text] [PDF]
|
|
|
|
|
|
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches Clin. Chem., June 1, 2006; 52(6): 950 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Powell, J. L. Dixon, G. A. Ramm, D. M. Purdie, D. J. Lincoln, G. J. Anderson, V. N. Subramaniam, D. G. Hewett, J. W. Searle, L. M. Fletcher, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med, February 13, 2006; 166(3): 294 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Brissot and F. de Bels Current Approaches to the Management of Hemochromatosis Hematology, January 1, 2006; 2006(1): 36 - 41. [Abstract] [Full Text] [PDF]
|
|